Satisfaction and side effects in 12 months of Jaydess® in a Portuguese Centre
ESC Congress Library. Djokovic D. 05/10/18; 208184; ESC289
Dusan Djokovic
Dusan Djokovic
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Abstract
Rate & Comment (0)
INTRODUCTION: The levonorgestrel intrauterine system (LNG-IUS) Jaydess®, in comparison with the LNG-IUS Mirena®, is smaller, releases a lower hormone dosage (13.5mg) and has a shorter time of action, being thereby considered advantageous for younger and/or nulliparous women. OBJECTIVES: This study was carried out to characterize the population of women attending our Institution, who chose Jaydess® as contraceptive, in terms of bleeding pattern, adverse event rates and satisfaction. In parallel, we aimed to compare the pain experienced during the Jaydess® insertion and other undesirable effects in nulliparous vs. multiparous women. DESIGN AND METHODS: The study included 153 women that chose Jaydess® at our Institution between January 2016 and July 2017. Those that had Jaydess® inserted at least a year ago (n=64) were contacted by phone and asked to answer a questionnaire. Obtained data were processed and analysed by the use of descriptive statistics and ANOVA. RESULTS: The mean age of the women included in the study was 28.6 ± 7.5 years. Eighty-one women (53.6%) were nulliparous. In 95 cases (62.1%), Jaydess® was inserted upon voluntary termination of pregnancy. Among 64 women that have Jaydess® inserted at least a year ago, 43 accepted to answer the study questionnaire. In this subgroup, 34 women (79.1%) maintained Jaydess® for at least one year while 9 women required Jaydess® removal due to its adverse effects or expulsed the IUS. Amenorrhoea was reported by 2 women (6.1%), irregular cycles by 15 (45.5%) while 16 women (48.5%) presented regular menstrual cycle duration. Commonly reported adverse effects included abnormal uterine haemorrhage (n=36, 85.7%), pelvic pain (n=28, 65.1%,) and vaginal discharge (n=19, 45.2%). However, most women were satisfied (n=18, 52.9%,) or very satisfied (n=11, 32.4%) with Jaydess®, and 79.4% (n=27) would use it again. No statistically significant difference was found between nulliparous and multiparous women regarding the pain level during IUS insertion and the rate of all adverse effects (p=0.169 and p=0.173, respectively). CONCLUSIONS: Most women with Jaydess® attending our Institution are young and nulliparous. Despite the study limitation due to a small sample, our results are in agreement with previously published data, indicating that it may present side effects (most frequently abnormal uterine haemorrhage), but generally women reported satisfaction, maintained the device and would use it again. No statistically significant difference was observed in nulliparous vs. multiparous women in respect with the pain experienced during the IUS insertion and other undesirable Jaydess® effects.
INTRODUCTION: The levonorgestrel intrauterine system (LNG-IUS) Jaydess®, in comparison with the LNG-IUS Mirena®, is smaller, releases a lower hormone dosage (13.5mg) and has a shorter time of action, being thereby considered advantageous for younger and/or nulliparous women. OBJECTIVES: This study was carried out to characterize the population of women attending our Institution, who chose Jaydess® as contraceptive, in terms of bleeding pattern, adverse event rates and satisfaction. In parallel, we aimed to compare the pain experienced during the Jaydess® insertion and other undesirable effects in nulliparous vs. multiparous women. DESIGN AND METHODS: The study included 153 women that chose Jaydess® at our Institution between January 2016 and July 2017. Those that had Jaydess® inserted at least a year ago (n=64) were contacted by phone and asked to answer a questionnaire. Obtained data were processed and analysed by the use of descriptive statistics and ANOVA. RESULTS: The mean age of the women included in the study was 28.6 ± 7.5 years. Eighty-one women (53.6%) were nulliparous. In 95 cases (62.1%), Jaydess® was inserted upon voluntary termination of pregnancy. Among 64 women that have Jaydess® inserted at least a year ago, 43 accepted to answer the study questionnaire. In this subgroup, 34 women (79.1%) maintained Jaydess® for at least one year while 9 women required Jaydess® removal due to its adverse effects or expulsed the IUS. Amenorrhoea was reported by 2 women (6.1%), irregular cycles by 15 (45.5%) while 16 women (48.5%) presented regular menstrual cycle duration. Commonly reported adverse effects included abnormal uterine haemorrhage (n=36, 85.7%), pelvic pain (n=28, 65.1%,) and vaginal discharge (n=19, 45.2%). However, most women were satisfied (n=18, 52.9%,) or very satisfied (n=11, 32.4%) with Jaydess®, and 79.4% (n=27) would use it again. No statistically significant difference was found between nulliparous and multiparous women regarding the pain level during IUS insertion and the rate of all adverse effects (p=0.169 and p=0.173, respectively). CONCLUSIONS: Most women with Jaydess® attending our Institution are young and nulliparous. Despite the study limitation due to a small sample, our results are in agreement with previously published data, indicating that it may present side effects (most frequently abnormal uterine haemorrhage), but generally women reported satisfaction, maintained the device and would use it again. No statistically significant difference was observed in nulliparous vs. multiparous women in respect with the pain experienced during the IUS insertion and other undesirable Jaydess® effects.
    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.


Save Settings